Myospas 10 Tablets

babies: it is not applicable. lactating mother: consult your doctor before using paracetamol, chlorzoxazone tablets during breastfeeding.
pregnancy: consult your doctor before using paracetamol, chlorzoxazone tablets during pregnancy. alcohol: it is not safe to consume alcohol with paracetamol, chlorzoxazone tablet.
driving: paracetamol, chlorzoxazone tablet may alter your ability to drive. do not drive if any symptoms affect you are driving.
kidney: paracetamol, chlorzoxazone tablets must be used with caution in patients with kidney disease. dose adjustment is required.
consult your doctor since it is a combination of two medicines where paracetamol is the safest painkiller for kidney disease patients. liver: paracetamol, chlorzoxazone tablets must be used with caution in patients with liver disease.
dose adjustment is required. consult your doctor.
this medication is not given in patients with server liver disease and active liver disease..

Stomach upset Dizziness Weakness Sleepiness.

MYOSPAS is analgesic and antipyretic. it works by blocking the production of certain chemical messengers in the brain which causes pain and fever.
chlorzoxazone is a skeletal muscle relaxant. it works by blocking nerve impulses or pain sensation that is sent to the brain.
therefore, it provides relief from muscle stiffness or spasm..

If you miss a dose of MYOSPAS, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• MYOSPAS tablet is prescribed to relieve pain caused by muscle spasm • along with medication, rest and physical therapy are required • do not drink alcohol while taking this medication because it can cause excessive drowsiness and increases the risk of liver damage • inform your doctor before taking any other medications for fever, pain, or cold • this medication may cause drowsiness, confusion, and risk of falling in older adults.

• paracetamol + imatinib: concurrent use may result in increased levels of paracetamol • paracetamol + isoniazid: concurrent use may result in an increased risk of hepatotoxicity • paracetamol + carbamazepine: concurrent use may result in an increased risk of hepatotoxicity • paracetamol + phenytoin: concurrent use may result in decreased paracetamol effectiveness and increased risk of hepatotoxicity • paracetamol + warfarin: concurrent use may result in an increased risk of bleeding • chlorzoxazone + alprazolam: concurrent use may result in additive respiratory depression • chlorzoxazone + bromazepam: concurrent use may result in an increased risk of respiratory or cardiovascular depression • chlorzoxazone + cannabidiol: concurrent use may result in an increased risk of sedation • chlorzoxazone + fentanyl: concurrent use may result in an increased risk of cns depression • chlorzoxazone + potassium oxybate: concurrent use may result in an increased risk of cns depression and respiratory depression, hypotension, profound sedation, syncope, and death.